CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Smith Kline & French Laboratories Ltd. manufactures pharmaceutical products. The company is headquartered in Brentford, the United Kingdom.

Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP

Nippon Zoki Pharmaceutical Co. Ltd. is a private company headquartered in Chuo-ku, Japan, that manufactures pharmaceutical products.

Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.

Shandong Tefaman Pharmaceutical Co., Ltd., established on 2004-11-13, Business scope includes pharmaceutical production;API,Pharmaceutical Intermediates,Research and development of health products,manufacture,Sales;Pharmaceutical Technology Development,consult,transfer,Promotion service;Chinese herbal medicine processing;Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Tehua Pharmaceutical Technology Co., Ltd., established on 2000-03-08, The scope of business includes self-operated or agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of,Pharmaceuticals and their intermediates,Fine Chemicals,Research on the above-mentioned professional technologies and products of health care products,to develop,technology transfer,technical consulting,Technical Services,Chemical Products(In addition to dangerous goods)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

The Boots Co. Plc owns and operates a chain of pharmaceutical and personal care retail stores. The firm’s stores are consists of local pharmacies, a healthcare-focused community stores; convenience and high-street stores offering pharmacy-led care. The company is headquartered in Nottingham, the United Kingdom.

Nanjing Zeheng Pharmaceutical Technology Development Co., Ltd., established on 2009-10-15, Business scope includes pharmaceuticals,Health products,Daily chemical products,food research,to develop,Technical consulting and technology transfer;Chemical Products(Does not contain hazardous chemicals),laboratory apparatus,laboratory consumables,Sales of daily necessities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Import and export;Technology Import and Export;Drug internet information service;Health food production;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:market survey(Does not include foreign investigations);Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.

Reckitt Benckiser Healthcare (UK) Ltd., a subsidiary of Reckitt Benckiser Group Plc, is a British company located in Slough. The firm manufactures household and sanitary goods. It was founded in 1931.\nThe company says this about itself: The principal activity of the company which is a Member of the Reckitt Benckiser group of companies is the manufacture and sale of branded consumer products for sale to other Group companies.

Microgenics Corp. manufactures and markets immunodiagnostic tests for drugs. The company was founded in 1986 and is headquartered in Waltham, MA.

Abbott Healthcare Pvt Ltd. engages in the provision of pharmaceuticals products. The company was founded in 1997 and is headquartered in Mumbai, India.

Charleston Laboratories, Inc is a specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting, the two most burdensome side effects related to opioid analgesics and other pain associated disease states. Charleston’s new products will address Opioid Induced Nausea and Vomiting (OINV), Postoperative Induced Nausea and Vomiting (PONV), Chemotherapy Induced Nausea and Vomiting (CINV), Radiation Induced Nausea and Vomiting (RINV) and Migraine Induced Nausea and Vomiting (MINV). In addition, Charleston is developing other products without acetaminophen to reduce the potential for liver injury and formulations with abuse deterrent technologies designed to curb misuse & abuse.

Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

R.P. Scherer GmbH & Co. KG, part of Catalent, Inc., is a company headquartered in Eberbach, Germany, that develops, manufactures and sells pharmaceutical products.

Daiichi Seiyaku Co., Ltd. engaged in the manufacture, sale research and development of medicine. The company was founded on October 1, 1915 and was headquartered in Tokyo, Japan.

Biophore is a developer and manufacturer of pharmaceutical products for the generic industry.